• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Northwest Biotherapeutics Inc

+ Add to Watchlist

NBYA:GR

3.967 EUR 0.010 0.25%

As of 02:00:42 ET on 04/17/2014.

Snapshot for Northwest Biotherapeutics Inc (NBYA)

Open: 4.038 Day's Range: 3.967 - 4.038 Volume: 0
Previous Close: 3.957 52wk Range: 2.013 - 7.490 1-Yr Rtn: -

Stock Chart for NBYA

No chart data available.
  • NBYA:GR 4.038
  • 1D
  • 1M
  • 1Y
3.957
Interactive NBYA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBYA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.5500
Est. PEG Ratio -
Market Cap (M EUR) 213.18
Shares Outstanding (M) 53.74
30 Day Average Volume 650
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBYA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBYA

Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.

Linda F PowersChairman/CEOAnthony E Maida IIIChief Operating Officer
Marnix L BoschChief Technology OfficerAlton L BoyntonChief Scientific Officer
More Company Profile & Key Executives for NBYA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil